India to launch its first indigenous vaccine against H5N1 bird flu in chickens
Developed by the ICAR-NIHSAD, the inactivated vaccine targets the H5N1 virus belonging to Clade 2.3.2.1a, a strain responsible for several bird flu outbreaks in chickens.
India will launch its first indigenously developed vaccine against the H5N1 bird flu virus in chickens on 20 November, marking a step towards strengthening the country’s preparedness to control outbreaks of highly pathogenic avian influenza.
Developed by the ICAR-National Institute of High Security Animal Diseases (ICAR-NIHSAD), Bhopal, the inactivated vaccine targets the H5N1 virus belonging to Clade 2.3.2.1a, a strain responsible for several bird flu outbreaks in chickens.
The vaccine is expected to protect against H5N1 strains of this clade circulating in India. Currently, no specific commercial vaccine is available against this strain, making the indigenous development significant for the country’s poultry sector.
Highly pathogenic avian influenza (HPAI), commonly known as bird flu, is a highly contagious disease that can cause mortality in nearly 100% of infected birds. Outbreaks often lead to large-scale culling, movement restrictions and trade disruptions, resulting in substantial financial losses for poultry farmers.
Since the first detection of bird flu in India in 2006, the country has reported more than 500 combined outbreaks involving the H5N1 and H5N8 subtypes.
The economic impact can extend beyond poultry farms. According to the government, a major bird flu outbreak could reduce India’s GDP growth by up to 1.5%, while more than 20% of the country’s poultry population could be at risk if the disease spreads without adequate control measures.
The 2006 outbreak alone caused estimated direct and indirect losses of Rs 2,200 crore to Rs 3,000 crore. An outbreak in Manipur also resulted in losses equivalent to 0.5% of the state’s GDP.
Bird flu is also a public health concern because certain strains of the virus can infect humans. According to the World Health Organisation (WHO), 1,003 human cases of H5N1 avian influenza, including 479 deaths, have been reported across 25 countries, including India, since 2003.
The H5N1 Clade 2.3.2.1a strain has also been detected in different animal species, including mammals. The government has cited three human cases associated with this strain, underlining the importance of controlling infections in poultry and preventing further transmission.
The indigenous vaccine is aimed at strengthening disease control in the poultry sector while reducing the risk of the virus spreading to other animals and humans.